Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas”

12,578 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 12,578 results

Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Not applicableWithdrawnNCT00657332
What this trial is testing

Clinical and Pathologic Studies in Neuroendocrine Tumors

Who this might be right for
Carcinoid TumorNeuroendocrine Tumors
Stanford University
Large-scale testing (Phase 3)Study completedNCT02420821
What this trial is testing

Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 915
Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Testing effectiveness (Phase 2)Looking for participantsNCT06383533
What this trial is testing

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

Who this might be right for
Bile Duct Adenocarcinoma Non-ResectableHER2 Gene Mutation
Zhejiang Cancer Hospital 28
Large-scale testing (Phase 3)UnknownNCT02773485
What this trial is testing

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tata Memorial Hospital 155
Not applicableActive Not RecruitingNCT02874885
What this trial is testing

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectosigmoid Adenocarcinoma+10 more
M.D. Anderson Cancer Center 341
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Not applicableStudy completedNCT03900364
What this trial is testing

A Prospective Trial Comparing Robot-assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy

Who this might be right for
Carcinoma, Renal CellRenal Malignant TumorRenal Cyst+1 more
Salzburger Landeskliniken 30
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Not applicableStudy completedNCT01662635
What this trial is testing

Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)

Who this might be right for
Non Small-cell Lung Cancer
Instituto Nacional de Cancerologia de Mexico 230
Early research (Phase 1)Ended earlyNCT02862535
What this trial is testing

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Gilead Sciences 36
Not applicableUnknownNCT04846192
What this trial is testing

Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma

Who this might be right for
Perihilar Cholangiocarcinoma
Central Hospital, Nancy, France 40
Early research (Phase 1)Looking for participantsNCT06257693
What this trial is testing

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Alessa Therapeutics Inc. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291885
What this trial is testing

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage II+3 more
Melanoma and Skin Cancer Trials Limited 122
Large-scale testing (Phase 3)UnknownNCT02409199
What this trial is testing

Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Carcinoma
Shanghai Zhongshan Hospital 66
Not applicableWithdrawnNCT01729832
What this trial is testing

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituRecurrent Breast Cancer+7 more
Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT04868149
What this trial is testing

Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Who this might be right for
Liver Cancer
The University of Hong Kong 40
Testing effectiveness (Phase 2)Ended earlyNCT01351038
What this trial is testing

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Who this might be right for
KRAS Wild TypeResectable Type II Gastric Adenocarcinoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 43
Load More Results